Kyntra Bio, Inc. (KYNB)
NASDAQ: KYNB · Real-Time Price · USD
6.93
-0.09 (-1.25%)
At close: May 29, 2026, 4:00 PM EDT
6.90
-0.03 (-0.46%)
After-hours: May 29, 2026, 4:10 PM EDT
Kyntra Bio Employees
Kyntra Bio had 34 employees as of December 31, 2025. The number of employees decreased by 191 or -84.89% compared to the previous year.
Employees
34
Change (1Y)
-191
Growth (1Y)
-84.89%
Revenue / Employee
$218,794
Profits / Employee
$4,812,206
Market Cap
27.93M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 34 | -191 | -84.89% |
| Dec 31, 2024 | 225 | -261 | -53.70% |
| Dec 31, 2023 | 486 | -106 | -17.91% |
| Dec 31, 2022 | 592 | 26 | 4.59% |
| Dec 31, 2021 | 566 | -33 | -5.51% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Celularity | 123 |
| IGC Pharma | 70 |
| Sensei Biotherapeutics | 29 |
| Lisata Therapeutics | 21 |
| NeuroSense Therapeutics | 17 |
| Serina Therapeutics | 16 |
| CervoMed | 15 |
| Barinthus Biotherapeutics | 14 |
KYNB News
- 19 days ago - Kyntra Bio Earnings Call Transcript: Q1 2026 - Transcripts
- 19 days ago - Kyntra Bio Earnings release: Q1 2026 - Filings
- 19 days ago - Kyntra Bio Slides: Q1 2026 - Filings
- 19 days ago - Kyntra Bio Quarterly report: Q1 2026 - Filings
- 19 days ago - Kyntra Bio Reports First Quarter 2026 Financial Results and Provides Business Update - GlobeNewsWire
- 26 days ago - Kyntra Bio to Report First Quarter 2026 Financial Results - GlobeNewsWire
- 4 weeks ago - Kyntra Bio Proxy statement: Proxy filing - Filings
- 4 weeks ago - Kyntra Bio Proxy statement: Proxy filing - Filings